Pathophysiology of Crohn's disease inflammation and recurrence

$ 26.00

4.7
(549)
In stock
Description

Chron’s Disease is a chronic inflammatory intestinal disease, first described at the beginning of the last century. The disease is characterized by the alternation of periods of flares and remissions influenced by a complex pathogenesis in which inflammation plays a key role. Crohn’s disease evolution is mediated by a complex alteration of the inflammatory response which is characterized by alterations of the innate immunity of the intestinal mucosa barrier together with a remodeling of the extracellular matrix through the expression of metalloproteins and increased adhesion molecules expression, such as MAcCAM-1. This reshaped microenvironment enhances leucocytes migration in the sites of inflammation, promoting a TH1 response, through the production of cytokines such as IL-12 and TNF-α. IL-12 itself and IL-23 have been targeted for the medical treatment of CD. Giving the limited success of medical therapies, the treatment of the disease is invariably surgical. This review will highlight the role of inflammation in CD and describe the surgical approaches for the prevention of the almost inevitable recurrence.

Crohn's disease and clinical management today: How it does?

Frontiers Diagnostic and Predictive Value of Immune-Related Genes in Crohn's Disease

Identification of hub genes and key pathways in pediatric Crohn's disease using next generation sequencing and bioinformatics analysis

New insights into the pathophysiology of inflammatory bowel disease: microbiota, epigenetics and common signalling pathways

Crohn's Disease An Ultimate Guide (Symptoms, Diet, Causes, Treatment)

Crohn's disease and clinical management today: How it does?

Patchouli Alcohol: a Natural Sesquiterpene Against Both Inflammation and Intestinal Barrier Damage of Ulcerative Colitis

Genetics and pathogenesis of inflammatory bowel disease

Sotetsuflavone ameliorates Crohn's disease-like colitis by inhibiting M1 macrophage-induced intestinal barrier damage via JNK and MAPK signalling - ScienceDirect

Immunopathogenesis of IBD: current state of the art

Pathophysiology of Crohn's Disease 17 .